A protocol for the preparation of cryoprecipitate and cryodepleted plasma

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Other

14 Citations (Scopus)

Abstract

Cryoprecipitate is a concentrate of high-molecular-weight plasma proteins that precipitate when frozen plasma is slowly thawed at 1a??6A?C. The concentrate contains factor VIII (antihemophilic factor), von Willebrand factor (vWF), fibrinogen, factor XIII, fibronectin, and small amounts of other plasma proteins. Clinical-grade preparations of cryoprecipitate are mainly used to treat fibrinogen deficiency caused by acute bleeding or functional abnormalities of the fibrinogen protein. In the past, cryoprecipitate was used to treat von Willebrand disease and hemophilia A (factor VIII deficiency), but the availability of more highly purified coagulation factor concentrates or recombinant protein preparations has superseded the use of cryoprecipitate for these coagulopathies. Cryodepleted plasma (a??cryosupernatanta??) is the plasma supernatant that remains following removal of the cryoprecipitate from frozen-thawed plasma. It contains all the other plasma proteins and clotting factors present in plasma that remain soluble during cold-temperature thawing of the plasma.
Original languageEnglish
Title of host publicationSerum/Plasma Proteomics: Methods and Protocols
EditorsRichard J Simpson, David W Greening
Place of PublicationUK
PublisherHumana Press
Pages259 - 265
Number of pages7
Volume728
ISBN (Print)9781617790676
DOIs
Publication statusPublished - 2011

Cite this

Sparrow, R., Greening, D. W., & Simpson, R. J. (2011). A protocol for the preparation of cryoprecipitate and cryodepleted plasma. In R. J. Simpson, & D. W. Greening (Eds.), Serum/Plasma Proteomics: Methods and Protocols (Vol. 728, pp. 259 - 265). UK: Humana Press. https://doi.org/10.1007/978-1-61779-068-3_17
Sparrow, Rosemary ; Greening, David W ; Simpson, Richard J. / A protocol for the preparation of cryoprecipitate and cryodepleted plasma. Serum/Plasma Proteomics: Methods and Protocols. editor / Richard J Simpson ; David W Greening. Vol. 728 UK : Humana Press, 2011. pp. 259 - 265
@inbook{ec94f3e863e1499d8bb99396907684ec,
title = "A protocol for the preparation of cryoprecipitate and cryodepleted plasma",
abstract = "Cryoprecipitate is a concentrate of high-molecular-weight plasma proteins that precipitate when frozen plasma is slowly thawed at 1a??6A?C. The concentrate contains factor VIII (antihemophilic factor), von Willebrand factor (vWF), fibrinogen, factor XIII, fibronectin, and small amounts of other plasma proteins. Clinical-grade preparations of cryoprecipitate are mainly used to treat fibrinogen deficiency caused by acute bleeding or functional abnormalities of the fibrinogen protein. In the past, cryoprecipitate was used to treat von Willebrand disease and hemophilia A (factor VIII deficiency), but the availability of more highly purified coagulation factor concentrates or recombinant protein preparations has superseded the use of cryoprecipitate for these coagulopathies. Cryodepleted plasma (a??cryosupernatanta??) is the plasma supernatant that remains following removal of the cryoprecipitate from frozen-thawed plasma. It contains all the other plasma proteins and clotting factors present in plasma that remain soluble during cold-temperature thawing of the plasma.",
author = "Rosemary Sparrow and Greening, {David W} and Simpson, {Richard J}",
year = "2011",
doi = "10.1007/978-1-61779-068-3_17",
language = "English",
isbn = "9781617790676",
volume = "728",
pages = "259 -- 265",
editor = "Simpson, {Richard J} and Greening, {David W}",
booktitle = "Serum/Plasma Proteomics: Methods and Protocols",
publisher = "Humana Press",
address = "United States of America",

}

Sparrow, R, Greening, DW & Simpson, RJ 2011, A protocol for the preparation of cryoprecipitate and cryodepleted plasma. in RJ Simpson & DW Greening (eds), Serum/Plasma Proteomics: Methods and Protocols. vol. 728, Humana Press, UK, pp. 259 - 265. https://doi.org/10.1007/978-1-61779-068-3_17

A protocol for the preparation of cryoprecipitate and cryodepleted plasma. / Sparrow, Rosemary; Greening, David W; Simpson, Richard J.

Serum/Plasma Proteomics: Methods and Protocols. ed. / Richard J Simpson; David W Greening. Vol. 728 UK : Humana Press, 2011. p. 259 - 265.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Other

TY - CHAP

T1 - A protocol for the preparation of cryoprecipitate and cryodepleted plasma

AU - Sparrow, Rosemary

AU - Greening, David W

AU - Simpson, Richard J

PY - 2011

Y1 - 2011

N2 - Cryoprecipitate is a concentrate of high-molecular-weight plasma proteins that precipitate when frozen plasma is slowly thawed at 1a??6A?C. The concentrate contains factor VIII (antihemophilic factor), von Willebrand factor (vWF), fibrinogen, factor XIII, fibronectin, and small amounts of other plasma proteins. Clinical-grade preparations of cryoprecipitate are mainly used to treat fibrinogen deficiency caused by acute bleeding or functional abnormalities of the fibrinogen protein. In the past, cryoprecipitate was used to treat von Willebrand disease and hemophilia A (factor VIII deficiency), but the availability of more highly purified coagulation factor concentrates or recombinant protein preparations has superseded the use of cryoprecipitate for these coagulopathies. Cryodepleted plasma (a??cryosupernatanta??) is the plasma supernatant that remains following removal of the cryoprecipitate from frozen-thawed plasma. It contains all the other plasma proteins and clotting factors present in plasma that remain soluble during cold-temperature thawing of the plasma.

AB - Cryoprecipitate is a concentrate of high-molecular-weight plasma proteins that precipitate when frozen plasma is slowly thawed at 1a??6A?C. The concentrate contains factor VIII (antihemophilic factor), von Willebrand factor (vWF), fibrinogen, factor XIII, fibronectin, and small amounts of other plasma proteins. Clinical-grade preparations of cryoprecipitate are mainly used to treat fibrinogen deficiency caused by acute bleeding or functional abnormalities of the fibrinogen protein. In the past, cryoprecipitate was used to treat von Willebrand disease and hemophilia A (factor VIII deficiency), but the availability of more highly purified coagulation factor concentrates or recombinant protein preparations has superseded the use of cryoprecipitate for these coagulopathies. Cryodepleted plasma (a??cryosupernatanta??) is the plasma supernatant that remains following removal of the cryoprecipitate from frozen-thawed plasma. It contains all the other plasma proteins and clotting factors present in plasma that remain soluble during cold-temperature thawing of the plasma.

UR - http://www.springer.com/new+%26+forthcoming+titles+(default)/book/978-1-61779-067-6

U2 - 10.1007/978-1-61779-068-3_17

DO - 10.1007/978-1-61779-068-3_17

M3 - Chapter (Book)

SN - 9781617790676

VL - 728

SP - 259

EP - 265

BT - Serum/Plasma Proteomics: Methods and Protocols

A2 - Simpson, Richard J

A2 - Greening, David W

PB - Humana Press

CY - UK

ER -

Sparrow R, Greening DW, Simpson RJ. A protocol for the preparation of cryoprecipitate and cryodepleted plasma. In Simpson RJ, Greening DW, editors, Serum/Plasma Proteomics: Methods and Protocols. Vol. 728. UK: Humana Press. 2011. p. 259 - 265 https://doi.org/10.1007/978-1-61779-068-3_17